Stroke News

Healio and Cardiology Today have aggregated a list of the most-read news in cardiology of July 2021.

Long-term testosterone therapy significantly reduced MI and stroke events in men with abnormally low testosterone levels, according to new data presented at the European Association of Urology Congress.

Metabolic syndrome demonstrated significant correlations with both stroke recurrence and all-cause mortality, according to the results of a meta-analysis of 13 cohort studies with nearly 60,000 participants published in Neurology.

Among patients who underwent left ventricular arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants were superior to aspirin in preventing cerebrovascular events, according to the results of the STROKE-VT trial.

Marijuana use was not associated with risk for ischemic stroke among young adults compared with never users, according to research published in Stroke.

Cleveland Clinic has been selected by U.S. News & World Report as the top U.S. hospital for cardiology and heart surgery, in the publication’s 2021-2022 Best Hospitals rankings.

Despite advances in the prevention and treatment of CVD, it remains the leading cause of death in women and men worldwide. Additionally, the absolute burden of CVD mortality in the U.S. is higher in women than in men.

Among older adults, all measures of ambulatory BP were associated with risk for stroke while office diastolic BP was only weakly associated, and central BP measures were not associated with stroke at all, researchers reported.

Among older adults with atrial fibrillation, apixaban was linked to lower rates of adverse events across all frailty levels compared with warfarin, a retrospective observational study showed.

The American Heart Association, the Society of Vascular and Interventional Neurology and John Wiley & Sons announced the launch of Stroke: Vascular and Interventional Neurology, a new peer-reviewed, open access journal.